Cargando…

Prognostic Biomarkers in Endometrial Cancer: A Systematic Review and Meta-Analysis

Endometrial cancer (EC) is the sixth most common cancer in women worldwide and its mortality is directly associated with the presence of poor prognostic factors driving tumor recurrence. Stratification systems are based on few molecular, and mostly clinical and pathological parameters, but these sys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coll-de la Rubia, Eva, Martinez-Garcia, Elena, Dittmar, Gunnar, Gil-Moreno, Antonio, Cabrera, Silvia, Colas, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356541/ https://www.ncbi.nlm.nih.gov/pubmed/32560580 http://dx.doi.org/10.3390/jcm9061900

Ejemplares similares

In silico Approach for Validating and Unveiling New Applications for Prognostic Biomarkers of Endometrial Cancer
por: Coll-de la Rubia, Eva, et al.
Publicado: (2021)

Cervical Fluids Are a Source of Protein Biomarkers for Early, Non-Invasive Endometrial Cancer Diagnosis
por: Martinez-Garcia, Elena, et al.
Publicado: (2023)

Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool
por: Villafranca-Magdalena, Beatriz, et al.
Publicado: (2022)

Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples
por: Martinez-Garcia, Elena, et al.
Publicado: (2016)

Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis
por: Altadill, Tatiana, et al.
Publicado: (2017)

Patient-Derived Xenograft Models for Endometrial Cancer Research
por: Moiola, Cristian P., et al.
Publicado: (2018)

Extracellular Vesicles-Based Biomarkers Represent a Promising Liquid Biopsy in Endometrial Cancer
por: Herrero, Carolina, et al.
Publicado: (2019)

Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools
por: Besso, María josé, et al.
Publicado: (2020)

Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer
por: Megino-Luque, Cristina, et al.
Publicado: (2020)

Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer
por: Casas-Arozamena, Carlos, et al.
Publicado: (2020)

EV-Associated miRNAs from Peritoneal Lavage are a Source of Biomarkers in Endometrial Cancer
por: Roman-Canal, Berta, et al.
Publicado: (2019)

FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways
por: Besso, María José, et al.
Publicado: (2019)

Current and Emerging Prognostic Biomarkers in Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2022)

Tissue Infiltrating Immune Cells as Prognostic Biomarkers in Endometrial Cancer: A Meta-Analysis
por: Guo, Fang, et al.
Publicado: (2020)

ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer
por: Devis, Laura, et al.
Publicado: (2018)

Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression
por: Mota, Alba, et al.
Publicado: (2022)

Modeling Endometrial Cancer: Past, Present, and Future
por: Van Nyen, Tom, et al.
Publicado: (2018)

Prognostic molecular biomarkers in endometrial cancer: A review
por: Hernández, J. Edgardo, et al.
Publicado: (2019)

The Prognostic Role of LRIG Proteins in Endometrial Cancer
por: Razumova, Zoia, et al.
Publicado: (2021)

Prognostic significance of CTNNB1 mutation in early stage endometrial carcinoma: a systematic review and meta-analysis
por: Travaglino, Antonio, et al.
Publicado: (2022)

Prognostic role of hormone receptors in endometrial cancer: a systematic review and meta-analysis
por: Zhang, Yanli, et al.
Publicado: (2015)

Multivariate Analysis of Prognostic Biomarkers in Surgically Treated Endometrial Cancer
por: Li, Jianpei, et al.
Publicado: (2015)

Bioinformatic screening for candidate biomarkers and their prognostic values in endometrial cancer
por: Li, Yaowei, et al.
Publicado: (2020)

Claudin-9 is a novel prognostic biomarker for endometrial cancer
por: Endo, Yuta, et al.
Publicado: (2022)

A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas
por: Creemers, Aafke, et al.
Publicado: (2018)

Enabling Metabolomics Based Biomarker Discovery Studies Using Molecular Phenotyping of Exosome-Like Vesicles
por: Altadill, Tatiana, et al.
Publicado: (2016)

BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity
por: Liu, Junxiu, et al.
Publicado: (2022)

Endometrial biopsy under direct hysteroscopic visualisation versus blind endometrial sampling for the diagnosis of endometrial hyperplasia and cancer: Systematic review and meta-analysis
por: Di Spiezio Sardo, A, et al.
Publicado: (2022)

FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies
por: Martínez-Aranda, Antonio, et al.
Publicado: (2015)

Clinicopathological characteristics and prognostic value of POLE mutations in endometrial cancer: A systematic review and meta-analysis
por: He, Ya, et al.
Publicado: (2020)

Systematic Review and Meta-Analyses of Aminopeptidases as Prognostic Biomarkers in Amyotrophic Lateral Sclerosis
por: Teruel-Peña, Bárbara, et al.
Publicado: (2023)

Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer
por: Latif, Ayşe, et al.
Publicado: (2017)

Screening of prognostic biomarkers for endometrial carcinoma based on a ceRNA network
por: Zheng, Ming-Jun, et al.
Publicado: (2018)

Diagnostic and prognostic value of HABP2 as a novel biomarker for endometrial cancer
por: Jiang, Ying, et al.
Publicado: (2020)

Mammaglobin B may be a prognostic biomarker of uterine corpus endometrial cancer
por: Li, Jie, et al.
Publicado: (2020)

TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer
por: Yang, Qiannan, et al.
Publicado: (2020)

Integrated Bioinformatics Analysis of Serine Racemase as an Independent Prognostic Biomarker in Endometrial Cancer
por: Cui, Zhiwei, et al.
Publicado: (2022)

An EMT-related genes signature as a prognostic biomarker for patients with endometrial cancer
por: Yu, Yonghui, et al.
Publicado: (2023)

The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis
por: Ryan, N. A. J., et al.
Publicado: (2019)

Adrenomedullin Is a Diagnostic and Prognostic Biomarker for Acute Intracerebral Hemorrhage
por: Julián-Villaverde, Francisco J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_de93rhd1q4jfg32f4puhsrhcph